Role Of Fdg Pet-ct In Evaluation Of Gastrointestinal Stromal Tumors als von
5 Angebote vergleichen

Lieferung aus: Deutschland, Versandkostenfrei.
Von Händler/Antiquariat, AHA-BUCH GmbH [51283250], Einbeck, Germany.
Neuware - Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors of the gastrointestinal tract. A definition of a new entity among the gastrointestinal mesenchymal tumors called the gastrointestinal stromal tumors (GISTs) which express the kit (CD117) protein a growth factor trans-membrane receptor with tyrosine kinase activity. Surgery is the mainstay of therapy for non-metastatic GISTs. The c-kit tyrosine kinase inhibitor Imatinib (Glivec), was found to be useful in treating GISTs, leading to a 40-70% response rate in metastatic or inoperable cases.The current Response Evaluation Criteria in solid tumors are based on uni-dimensional tumor size, and do not take into account changes in responding GISTs such as a decrease in tumor density and decrease in the number of intra-tumoral vessels with CT. PET/CT is highly sensitive in assessment early response to Imatinib mesylate. Also, it is useful in predicting long-term response to imatinib in patients with metastatic GIST; however, widespread use of PET is limited because of cost constraints. 72 pp. Englisch.

Lieferung aus: Deutschland, Lieferzeit: 6 Tage.
Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors of the gastrointestinal tract. A definition of a new entity among the gastrointestinal mesenchymal tumors called the gastrointestinal stromal tumors (GISTs) which express the kit (CD117) protein a growth factor trans-membrane receptor with tyrosine kinase activity. Surgery is the mainstay of therapy for non-metastatic GISTs. The c-kit tyrosine kinase inhibitor Imatinib (Glivec), was found to be useful in treating GISTs, leading to a 40-70% response rate in metastatic or inoperable cases.The current Response Evaluation Criteria in solid tumors are based on uni-dimensional tumor size, and do not take into account changes in responding GISTs such as a decrease in tumor density and decrease in the number of intra-tumoral vessels with CT. PET/CT is highly sensitive in assessment early response to Imatinib mesylate. Also, it is useful in predicting long-term response to imatinib in patients with metastatic GIST however, widespread use of PET is limited because of cost constraints.

Lieferung aus: Deutschland, Versandkosten nach: Deutschland.
Von Händler/Antiquariat, Buchhandlung Hoffmann, [3174608].
Neuware - Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors of the gastrointestinal tract. A definition of a new entity among the gastrointestinal mesenchymal tumors called the gastrointestinal stromal tumors (GISTs) which express the kit (CD117) protein a growth factor trans-membrane receptor with tyrosine kinase activity. Surgery is the mainstay of therapy for non-metastatic GISTs. The c-kit tyrosine kinase inhibitor Imatinib (Glivec), was found to be useful in treating GISTs, leading to a 40-70% response rate in metastatic or inoperable cases.The current Response Evaluation Criteria in solid tumors are based on uni-dimensional tumor size, and do not take into account changes in responding GISTs such as a decrease in tumor density and decrease in the number of intra-tumoral vessels with CT. PET/CT is highly sensitive in assessment early response to Imatinib mesylate. Also, it is useful in predicting long-term response to imatinib in patients with metastatic GIST however, widespread use of PET is limited because of cost constraints. 04.08.2017, Taschenbuch, Neuware, 220x150x4 mm, 124g, 72, Internationaler Versand, offene Rechnung (Vorkasse vorbehalten), sofortueberweisung.de, Selbstabholung und Barzahlung, Skrill/Moneybookers, PayPal, Lastschrift, Banküberweisung.

Von Händler/Antiquariat, European-Media-Service Mannheim [1048135], Mannheim, Germany.
Publisher/Verlag: LAP Lambert Academic Publishing | Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors of the gastrointestinal tract. A definition of a new entity among the gastrointestinal mesenchymal tumors called the gastrointestinal stromal tumors (GISTs) which express the kit (CD117) protein a growth factor trans-membrane receptor with tyrosine kinase activity. Surgery is the mainstay of therapy for non-metastatic GISTs. The c-kit tyrosine kinase inhibitor Imatinib (Glivec), was found to be useful in treating GISTs, leading to a 40-70% response rate in metastatic or inoperable cases.The current Response Evaluation Criteria in solid tumors are based on uni-dimensional tumor size, and do not take into account changes in responding GISTs such as a decrease in tumor density and decrease in the number of intra-tumoral vessels with CT. PET/CT is highly sensitive in assessment early response to Imatinib mesylate. Also, it is useful in predicting long-term response to imatinib in patients with metastatic GIST; however, widespread use of PET is limited because of cost constraints. | Format: Paperback | Language/Sprache: english | 72 pp.

Lieferung aus: Deutschland, Versandfertig in 1 - 2 Werktagen, Versandkostenfrei.
Von Händler/Antiquariat, expressbuch24.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen